174 related articles for article (PubMed ID: 26657567)
21. DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.
Menendez JA; Vellon L; Lupu R
Int J Mol Med; 2006 Dec; 18(6):1081-7. PubMed ID: 17089011
[TBL] [Abstract][Full Text] [Related]
22. Correlations of TOP2A gene aberrations and expression of topoisomerase IIα protein and TOP2A mRNA expression in primary breast cancer: a retrospective study of 86 cases using fluorescence in situ hybridization and immunohistochemistry.
Meng H; Chen R; Li W; Xu L; Xu L
Pathol Int; 2012 Jun; 62(6):391-9. PubMed ID: 22612507
[TBL] [Abstract][Full Text] [Related]
23. Topoisomerase II alpha is required for embryonic development and liver regeneration in zebrafish.
Dovey M; Patton EE; Bowman T; North T; Goessling W; Zhou Y; Zon LI
Mol Cell Biol; 2009 Jul; 29(13):3746-53. PubMed ID: 19380487
[TBL] [Abstract][Full Text] [Related]
24. Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell lines.
Nakagawa T; Hayashita Y; Maeno K; Masuda A; Sugito N; Osada H; Yanagisawa K; Ebi H; Shimokata K; Takahashi T
Cancer Res; 2004 Jul; 64(14):4826-32. PubMed ID: 15256452
[TBL] [Abstract][Full Text] [Related]
25. Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Nikolényi A; Sükösd F; Kaizer L; Csörgo E; Vörös A; Uhercsák G; Ormándi K; Lázár G; Thurzó L; Brodowicz T; Kahán Z
Oncology; 2011; 80(3-4):269-77. PubMed ID: 21734419
[TBL] [Abstract][Full Text] [Related]
26. Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes.
Varga Z; Moelans CB; Zuerrer-Hardi U; Ramach C; Behnke S; Kristiansen G; Moch H
Breast Cancer Res Treat; 2012 Jun; 133(3):929-35. PubMed ID: 22083232
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-139 suppresses proliferation in luminal type breast cancer cells by targeting Topoisomerase II alpha.
Hua W; Sa KD; Zhang X; Jia LT; Zhao J; Yang AG; Zhang R; Fan J; Bian K
Biochem Biophys Res Commun; 2015 Aug; 463(4):1077-83. PubMed ID: 26079880
[TBL] [Abstract][Full Text] [Related]
28. Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms.
Deng S; Yan T; Jendrny C; Nemecek A; Vincetic M; Gödtel-Armbrust U; Wojnowski L
BMC Cancer; 2014 Nov; 14():842. PubMed ID: 25406834
[TBL] [Abstract][Full Text] [Related]
29. Topoisomerase II regulates the maintenance of DNA methylation.
Lu LY; Kuang H; Korakavi G; Yu X
J Biol Chem; 2015 Jan; 290(2):851-60. PubMed ID: 25451918
[TBL] [Abstract][Full Text] [Related]
30. Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression.
Tretiakova M; Turkyilmaz M; Grushko T; Kocherginsky M; Rubin C; Teh B; Yang XJ
J Clin Pathol; 2006 Dec; 59(12):1272-7. PubMed ID: 16556665
[TBL] [Abstract][Full Text] [Related]
31. Selective killing of G2 decatenation checkpoint defective colon cancer cells by catalytic topoisomerase II inhibitor.
Jain CK; Roychoudhury S; Majumder HK
Biochim Biophys Acta; 2015 May; 1853(5):1195-204. PubMed ID: 25746763
[TBL] [Abstract][Full Text] [Related]
32. Small Molecule Inhibitors Confirm Ubiquitin-Dependent Removal of TOP2-DNA Covalent Complexes.
Swan RL; Poh LLK; Cowell IG; Austin CA
Mol Pharmacol; 2020 Sep; 98(3):222-233. PubMed ID: 32587095
[TBL] [Abstract][Full Text] [Related]
33. DNA topoisomerase II is dispensable for oocyte meiotic resumption but is essential for meiotic chromosome condensation and separation in mice.
Li XM; Yu C; Wang ZW; Zhang YL; Liu XM; Zhou D; Sun QY; Fan HY
Biol Reprod; 2013 Nov; 89(5):118. PubMed ID: 24048577
[TBL] [Abstract][Full Text] [Related]
34. TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer.
Moretti E; Desmedt C; Biagioni C; Regan MM; Oakman C; Larsimont D; Galardi F; Piccart-Gebhart M; Sotiriou C; Rimm DL; Di Leo A
Future Oncol; 2013 Oct; 9(10):1477-87. PubMed ID: 24106899
[TBL] [Abstract][Full Text] [Related]
35. Anthracenedione-methionine conjugates are novel topoisomerase II-targeting anticancer agents with favorable drug resistance profiles.
Lee CH; Hsieh MY; Hsin LW; Chen HC; Lo SC; Fan JR; Chen WR; Chen HW; Chan NL; Li TK
Biochem Pharmacol; 2012 May; 83(9):1208-16. PubMed ID: 22306066
[TBL] [Abstract][Full Text] [Related]
36. TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy.
Wang J; Xu B; Yuan P; Zhang P; Li Q; Ma F; Fan Y
Breast Cancer Res Treat; 2012 Sep; 135(2):531-7. PubMed ID: 22864769
[TBL] [Abstract][Full Text] [Related]
37. Decatenation checkpoint-defective melanomas are dependent on PI3K for survival.
Brooks K; Ranall M; Spoerri L; Stevenson A; Gunasingh G; Pavey S; Meunier F; Gonda TJ; Gabrielli B
Pigment Cell Melanoma Res; 2014 Sep; 27(5):813-21. PubMed ID: 24890688
[TBL] [Abstract][Full Text] [Related]
38. Centromere DNA decatenation depends on cohesin removal and is required for mammalian cell division.
Wang LH; Mayer B; Stemmann O; Nigg EA
J Cell Sci; 2010 Mar; 123(Pt 5):806-13. PubMed ID: 20144989
[TBL] [Abstract][Full Text] [Related]
39. Rif1 Is Required for Resolution of Ultrafine DNA Bridges in Anaphase to Ensure Genomic Stability.
Hengeveld RC; de Boer HR; Schoonen PM; de Vries EG; Lens SM; van Vugt MA
Dev Cell; 2015 Aug; 34(4):466-74. PubMed ID: 26256213
[TBL] [Abstract][Full Text] [Related]
40. Shikonin shortens the circadian period: possible involvement of Top2 inhibition.
Ogawa Y; Kawano Y; Yamazaki Y; Onishi Y
Biochem Biophys Res Commun; 2014 Jan; 443(1):339-43. PubMed ID: 24321095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
